INDIANAPOLIS, Oct. 6 (UPI) -- Eli Lilly and Co. said Monday it had reached an agreement to purchase New York's ImClone Systems Inc., a leading cancer-drug company, for $6.5 billion.
INDIANAPOLIS, Aug. 20 (UPI) -- Indianapolis pharmaceutical giant Eli Lilly went on a shopping spree Wednesday, closing one major deal and reaching a purchase agreement for Posilac.
INDIANAPOLIS, May 12 (UPI) -- Eli Lilly and Co. announced Monday the completion of the final phase of its biotechnology research and development headquarters in Indianapolis.
SOUTHFIELD, Mich., Feb. 9 (UPI) -- Auto-seating maker Lear Corp. said Friday it has agreed to U.S. investor Carl Icahn's $2.75 billion buyout offer but may solicit alternative proposals. The $36-a-share deal by Icahn's American Real Estate Partners is expected to close by June, the Southfi
SOUTHFIELD, Mich., Feb. 5 (UPI) -- Billionaire U.S. investor Carl Icahn has told auto-seating maker Lear Corp. he wants to buy the company for $36 a share, or $2.75 billion, Lear said Monday.
SCHAUMBURG, Ill., Jan. 30 (UPI) -- New York billionaire financier Carl Ichan is seeking nomination to Motorola Inc.'s board of directors, the Illinois-based cell phone maker said Tuesday. Motorola said it received a notice that Icahn "may be deemed to beneficially own, in the aggregate, 33
NEW YORK, Oct. 25 (UPI) -- Activist investor Carl Icahn has been named the chairman of ImClone Systems Inc. after a lengthy battle for control of the U.S. pharmaceutical company.
CINCINNATI, Sept. 27 (UPI) -- Activist investor Carl Icahn has advised Federated Department Stores Inc. he is increasing his investment in the U.S. department store chain.
SEOUL, March 14 (UPI) -- A South Korean court has dealt a setback to Carl Icahn's effort to take over KT&G Corp., the nation's biggest tobacco company.
INDIANAPOLIS, Dec. 22 (UPI) -- The Indianapolis-based Eli Lilly & Co. has reportedly agreed to pay a $36 million fine for off-label promotion of its Evista osteoporosis treatment.
NEW YORK, April 29 (UPI) -- U.S. financier Carl Icahn made $250 million on ImClone shares he bought the fateful day Martha Stewart sold hers, the Wall Street Journal reported.
